Drug-resistant Tuberculosis: Clinical Trials

3 trials for Drug-resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 2, Unknown 1
Phase 31Completed 1

Follow Drug-resistant Tuberculosis: new trials by email Literature Review of Drug-resistant Tuberculosis trials Research Report on Drug-resistant Tuberculosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study of JDB0131 Benzenesulfonate Tablets in Patients With Drug-sensitive Pulmonary Tuberculosis
JDB0131, Delamanid, Ethylpyrazine rifampicide (II) - Drug-resistant Tuberculosis
Phase 2UnknownBeijing Chest Hospital522023-10-312024-01-25
A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis
Pretomanid, Bedaquiline, moxifloxacin - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant
Phase 2CompletedGlobal Alliance for TB Drug Development262021-09-162025-01-17
Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients
Pretomanid, Bedaquiline, Moxifloxacin - Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant
Phase 2 / Phase 3CompletedGlobal Alliance for TB Drug Development4552018-07-302026-08-27

Narrower conditions

Tuberculosis, Multidrug-Resistant (3)  ·  Tuberculosis (2)  ·  Tuberculosis, Pulmonary (2)  ·  Extensively Drug-Resistant Tuberculosis (1)

Broader conditions

Actinomycetales Infections (3)  ·  Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)  ·  Mycobacterium Infections (3)  ·  Lung Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Infections (2)  ·  Tuberculosis (1)

Interventions

Moxifloxacin (2)  ·  Pyrazinamide (2)  ·  bedaquiline (2)  ·  pretomanid (2)  ·  Ethambutol (1)  ·  Isoniazid (1)  ·  OPC-67683 (1)  ·  Rifampin (1)

Sponsors

Global Alliance for TB Drug Development (2)  ·  Beijing Chest Hospital (1)

Countries

Georgia (2)  ·  South Africa (2)  ·  Brazil (1)  ·  China (1)  ·  Malaysia (1)  ·  Philippines (1)  ·  Russia (1)  ·  Tanzania (1)  ·  Uganda (1)

Top investigators

Antonio Lombardi, MD (1)  ·  Morounfolu Olugbosi, MD MSc (1)

Results publications

PMID 38768617, PMID 41461639